Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Bexsero Antibody Persistence and Booster
NCT01894919Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2013
- Primary completion
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of recombinant neisseria meningitidis group B nhba fusion protein in meningococcal disease, sponsored by Novartis. Started Jun 2013; status: completed.
02
Drugs
recombinant neisseria meningitidis group B nhba fusion protein
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01894919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894919.